All posts by imreal

Author Shares an Enlightening View About Racial Unity and Reconciliation As Noted in Scripture and Historical Facts


News Image

After seeing all the cyclical division in our nation, I felt compelled to help believers become bridge builders for Christ who were equipped to help close the cultural divide.

Author Khori Smith shares a compelling view of the church’s role with healing the nation’s racial issues in Bridges Between US: A Pathway to Unity Through Faith, Empathy & Mutual Understanding ($20.49, paperback, 9781662855092; $31.49, hardcover, 9781662855108; $8.99, e-book, 9781662855115).

According to Smith, many believers hope for racial unity and reconciliation within the walls of the church, in the communities and throughout the world. He explains that people allow fear and misunderstanding to overwhelm and paralyze themselves, sending them running back to safe circles and camps. Acknowledging that the world is in desperate need of a re-frame, except as Smith points out, one without pointed fingers, political rhetoric or taking sides. He believes that now is the ideal time for all to cast aside ideologies and instead, take the side of Christ, to disarm, free, equip and unite all people.

In this book, Smith illustrates God’s unquestionable desire for unity as highlighted in Scripture and also points out some important U.S. and world historical events that shine a light on current culture. More importantly, Smith includes practical solutions and tools to facilitate personal growth and equip churches to move towards authentic unity. He aims to empower the Church to be an agent of positive change and healing to the cyclical, divisive racial issues plaguing the nation. This book is written for those who are open-minded and willing to intently listen to his thought-provoking view.

When asked what inspired the author to write this book, Smith said, “After seeing all the cyclical division in our nation, I felt compelled to help believers become bridge builders for Christ who were equipped to help close the cultural divide.”

Khori Smith is the Teaching Pastor at Grace Fellowship Church in Baltimore County, Maryland. He has the privilege of encouraging and inspiring thousands of people in their faith online and in-person weekly. In this role, he takes relevant, everyday topics and applies spiritual truths in a way that makes them palatable and relatable to the everyday person. Smith is also a Chaplain with the NFL Alumni, acting as a spiritual coach that works directly with retired NFL football players as they transition from the NFL to life after football. He encourages players in “one on one” formats and leads group sessions that inspire retired players to discover and maintain their purpose in life.

Smith received his master’s degree from Howard University in Washington, D.C. His life’s mission is to build bridges between all people, all colors, all cultures and all communities. His greatest desire is to see people walk in oneness and unity, rooted in authentic relationships. Smith also has extensive experience working as a waiter in the hospitality industry and thus is a sought-after amateur foodie and dessert connoisseur. He lives with his supportive wife and two brilliant sons in Timonium, Maryland.

Editor of Smith’s book, Michele Reber, holds a Bachelor of Arts degree in Film and Video Production from Pennsylvania State University and an MBA from Johns Hopkins University. She is the Managing Director of Operations at Omega Healthcare Investors, where she performs copy and content editing. Outside of her job, Reber supports family and friends who are brave enough to attempt something so ambitious as publishing a book. When she is not working or editing, Michele enjoys being out in nature spending time with her Creator, especially while hiking or kayaking.

###

Xulon Press, a division of Salem Media Group, is the world’s largest Christian self-publisher, with more than 15,000 titles published to date. Bridges Between US: A Pathway to Unity Through Faith, Empathy & Mutual Understanding is available online through xulonpress.com/bookstore, amazon.com, and barnesandnoble.com.

Share article on social media or email:

Gerrit Coetzee’s newly released “Not So Forbidden” is a compelling discussion of lesbianism and scripture


News Image

“Not So Forbidden”: an engaging look into the permissibility and acceptance of same-sex partners for women. “Not So Forbidden” is the creation of published author Gerrit Coetzee.

Coetzee shares, “Not so forbidden.

“What is this hype all about?

“It is about lesbianism not being a sin.”

“It is a bold statement, very bold, and would not be made without proper and thorough counsel.

“It sets out to educate that the prevailing interpretation of Romans 1 in the Bible is incorrect. It is not, never was about inter-female relations, and it is proven within, why it cannot be about the damnation of lesbians.

“The script is set to alter historical believes, setting aside fraudulent teachings. It is tough to get the message across, when there are men and women who blindly refuse to accept an opposing reality.

“Shamingly, ordinary people resist the evidence, but the truth will burst through.

“One woman replied, ‘Gerrit, I am not an atheist, but I did lose faith in Christianity because of this issue. I will study your views, and if you are right, I will return to Christ.’

“Well, time will tell if one soul was won.”

Published by Christian Faith Publishing, Gerrit Coetzee’s new book is a challenge to common beliefs related to what God has said about women sharing committed relationships with other women.

Coetzee shares an engaging argument within the pages of this articulate and carefully researched work.

Consumers can purchase “Not So Forbidden” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Not So Forbidden,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Author Paul Wesay’s new book “Building a Better Liberia If I Am President” shares the author’s imperative dream for his country in light of an upcoming election


News Image

Paul Wesay, a faith leader, pastor, life coach, and a successful Realtor living in the United States in Atlanta, Georgia, has completed his new book “Building a Better Liberia If I Am President”: a gripping and potent work that discusses the current state of Liberia, providing goals and solutions for moving forward in a positive direction.

Author Paul Wesay discusses his work, writing, “Liberians living both at home and in the diaspora know that our country is headed in the wrong direction. From one failed leadership to another poor governance, the hopes of the people have been dashed or dismissed from one election cycle to the next. Politicians use false promises as a means to ascend to power, knowing they have selfish aims and ambitions to enrich themselves and their friends and families at the detriment of the poor Liberian people. The question now is, who can we trust? After 173 plus years, our country has not been able to make the transition from an agrarian society to a modern society where we have quality education that is accredited, a quality health-care system that is affordable and accessible, a country free from corruption, a country free from poverty, a quality road connectivity, safe drinking water, electricity, a justice system that has respect for the rule of law, a president who is more focused on development and modernization, and has respect for human lives.”

He continues, “our leaders of the past and most recent have been bankrupt in their thinking, and what we need now is a visionary and an energetic president backed by a group of leaders who believe in building a better Liberia than what our generation has inherited. When we do that, future generations will look back on us and say about us that this was the generation that rose up to the occasion and finally solved Liberia’s challenges. This is the time to restore democracy and integrity to the Liberian presidency.”

Published by Page Publishing, Paul Wesay’s engaging work invites readers to consider the implications of the 2023 presidential election.

Readers who wish to experience this informative work can purchase “Building a Better Liberia If I Am President” at bookstores everywhere, or online at the Apple iTunes Store, Amazon, Google Play, or Barnes and Noble.

For additional information or media inquiries, contact Page Publishing at 866-315-2708.

About Page Publishing:

Page Publishing is a traditional, full-service publishing house that handles all the intricacies involved in publishing its authors’ books, including distribution in the world’s largest retail outlets and royalty generation. Page Publishing knows that authors need to be free to create, not mired in logistics like eBook conversion, establishing wholesale accounts, insurance, shipping, taxes, and so on. Page’s accomplished writers and publishing professionals allow authors to leave behind these complex and time-consuming issues and focus on their passion: writing and creating. Learn more at http://www.pagepublishing.com.

Share article on social media or email:

CurlyKids HairCare Joins 9 Story Media Group and Karma’s World Entertainment on Licensing Deal with Icon Chris ‘Ludacris’ Bridges’ Animated Series Karma’s World


CurlyKids HairCare logo

CurlyKids HairCare logo

“This is an exciting opportunity to be a part of something so important not only for Black media or entertainment, but also Black-centric animation and children’s programming,” Charles Bordenave, Co-Founder of CurlyKids HairCare

Multimillion dollar Black-owned family-operated company CurlyKids HairCare is announcing a licensing partnership with 9 Story Media Group and Karma’s World Entertainment for the acclaimed animated series Karma’s World, inspired by Chris ‘Ludacris’ Bridges. The Black hair care company prominently known for creating products that cater to natural hair styles will be releasing Karma’s World by CurlyKids detangling shampoo, detangling conditioner and a detangling spray at FAO Schwarz, Target, Walmart, Kroger and Sally Beauty stores later this month. The licensing deal was secured by 9 Story Brands, 9 Story’s dedicated consumer products and brand management division.

“This is an exciting opportunity to be a part of something so important not only for Black media or entertainment, but also Black-centric animation and children’s programming,” said Charles Bordenave.

“I’m of course familiar with ‘Luda’, Mr. Bridges through his music and acting. But to see him pivot his influence and vision in this manner is especially near to my heart. As a girl dad myself, it is a gift to be living in a world where the landscape of kids’ shows is becoming so diverse and changing for the better. And though my daughter is well out of the demographic range for Karma’s World, she will always be my little girl, and as a family we will celebrate the show just the same.”

“We are so excited to welcome CurlyKids to the Karma’s World program,” said Kyra Halperin, Co-VP, Consumer Products at 9 Story Brands. “Black-owned businesses have been historically underrepresented within the licensing industry and it’s critical that we work with partners that align with the DNA of the brand, and achieve better representation on-shelf. We are thrilled to work with first-time licensee CurlyKids HairCare which has been inspiring Black children through representation to show their bold, beautiful and dynamic hair styles.”

Bridges, the rapper, actor, producer, entrepreneur and philanthropist, was originally inspired to create the show by his oldest daughter. Karma’s World, which premiered globally on Netflix on October 15, 2021, follows 10-year-old Karma Grant, an aspiring musical artist, and rapper with big talent and an even bigger heart. Every episode is infused with hip-hop music, streetwear fashion, and original choreography. The series focuses on themes of self-expression, identity, leadership, creativity, and the importance of community. A third season launched on July 7th. CurlyKids joins over 50 licensees on the brand across multiple categories, including global partnerships with Mattel, Scholastic and Universal Music Group.

About CurlyKids Mixed Texture HairCare:

CurlyKids Mixed Texture HairCare is a black-owned and family-operated business based in Los Angeles, CA. Since 2010, CurlyKids Mixed Texture HairCare has continued to support children’s hair journeys with affordable, quality products. Curly Kids Mixed Texture was developed for Curly, Kinky, Coily, Wavy, and Frizzy Hair. Their products are sulfate and paraben free and are available at select Burlington, Citi Trends, Kroger, Sally Beauty, Target, and Walmart stores or online at http://CurlyKidsHairCare.com

About 9 Story Brands

9 Story Brands is the dedicated brand management and consumer products division of 9 Story Media Group, a leading content creator, producer and distributor of kids and family focused intellectual property. 9 Story Brands builds international entertainment brands for kids, with expertise across creative, brand marketing and licensing. 9 Story Brands manages merchandising rights for top children’s properties including Daniel Tiger’s Neighborhood, Clifford The Big Red Dog, Colorforms, Wild Kratts, Super Why! and Karma’s World. http://www.9story.com

About Karma’s World Entertainment

Karma’s World Entertainment, founded by Chris Bridges, is an entertainment media company dedicated to helping kids develop self-esteem, healthy living, creativity and leadership skills through fun music and problem-solving educational programs, with an appreciation for diversity.

About Chris Bridges

Chris Bridges, sometimes professionally known as “Ludacris” is a successful actor, producer, entrepreneur and philanthropist as well as one of pop music’s most successful recording artists. Chris currently lives in Atlanta, Georgia. His love for his community led him to found The Ludacris Foundation (TLF), in 2001. This nonprofit organization seeks to inspire youth through education and memorable experiences and to uplift families and communities, while fostering economic development. For more information on TLF check out theludacrisfoundation.org.

About Vibrancy Agency

An illuminated approach to creating resonant branding. Vibrancy Agency, a black-owned women-led Public Relations & Marketing firm, illuminates the energy and life of Fashion, Beauty, Curve, Multicultural, and Socially-Conscious brands.

https://www.vibrancyagency.com

Share article on social media or email:

Domain Brokerage Firm Prime Loyalty Has Acquired The Exclusive Right To Sell Two Ultra-Premium Domain Assets : Derm.com and Braces.com


derm.com and braces.com 4 letter and 6 letter elite .com domain names

Prime Loyalty is offering Derm.com and Braces.com as game changing digital assets. These domain names present a rare opportunity for company CEOs or Chief Marketing Officers to raise their corporation to the next level of success.

Derm.com and Braces.com are ultra-rare, one-word, category-defining domain names which are still unbranded. Each has seen only very limited previous use by a private practice dermatologist and a private practice orthodontist. Clearly underutilized and underdeveloped, each of these powerful internet properties, along with the right corporate strategy, can now be leveraged and scaled worldwide.

Derm.com and Braces.com are ideal domain names for capturing the Dermatology and Orthodontic/Aligner consumer markets. One-word exact match names enable a corporation’s brand to achieve the ideal digital footprint. Once sold, these two yet to be developed domains will probably never be available again.

Easy to pronounce, easy to spell, and easy to remember, the 4 letter Derm.com brand is short and simple. It nevertheless represents the entire broad field of skin care and dermatology. “Derm” is also a universal term clearly understood in many languages. It ensures easy and effective corporate branding and advertising worldwide.

Likewise, for targeting consumers seeking a more beautiful smile, the simple and easy to remember Braces.com brand may be the most credible and referable online destination for information on aligners, braces, and all things orthodontic. Jeff Garbutt of Prime Loyalty reports that, “ Although we have seen some people searching for aligners, the keyword ‘aligners’ is nevertheless only searched for approximately 8,100 times a month as opposed to 246K times a month for ‘braces’. Therefore, it seems that ultimately consumers in the market for orthodontic products and services, including aligners, are also still largely using the search term ‘braces’.”

The demand for aesthetic skin care AND beautiful orthodontic smiles continues to grow, but so does the market competition. Derm.com and Braces.com easily empower a company to develop a competitive marketing edge. These two domain assets are being sold separately, but the pair may also be offered together as one package.

According to Fortune Business Insights, the global dermatology drug market size was $36.82 billion in 2019 and derm pharmaceuticals are projected to reach $63.99 billion by 2027, exhibiting a CAGR of 12.9% during the forecast period. The orthodontic market is expected to grow from $5.38 billion in 2021 to $16.36 billion in 2028 at a CAGR of 17.2% between 2021 and 2028.

As per UberSuggest web statistics, the keyword “derm” is searched 450,000 times a month in the U.S. with advertisers paying $3.59 CPC. For a 12-month period, that equates to $19,386,000 annually that the keyword “derm” is producing in advertising fees. “Braces” has an average of 246,000 searches a month in the U.S. and advertisers are paying approximately $15.14 CPC in advertising fees. That equates to approximately $44,693,280 ANNUALLY in advertising fees for the keyword “braces”. As noted earlier by domain broker Jeff Garbutt, it seems that ultimately consumers in the market for orthodontic products and services, including aligners, are also still largely using the search term “braces”.

Finally, many specific metrics are used to valuate a domain including: Age, Word Length, Ease of Spelling, SEO, Search Volume, Keyword CPC, Universality/Memorability, and Industry Type. These two assets check all the boxes.

Short, meaningful one-word .com domain names ideally position a business in terms of branding, marketing, SEO, email security, and trust in today’s ever expanding digital space. They drive sales and customer acquisitions, decrease marketing costs, enhance corporate brand awareness, accelerate growth, and enable any company to be more easily remembered, located, and referenced.

Prime Loyalty is offering Derm.com and Braces.com as game changing digital assets. These domain names present a rare opportunity for company CEOs or Chief Marketing Officers to raise their corporation to the next level of success.

About Prime Loyalty:

Prime Loyalty is a full-service domain brokerage specializing in acquiring and selling domain name assets, domain consulting, and branding. Jeff Garbutt of Prime Loyalty states, “Our company is built on relationships, loyalty, and expertise. We have been in the domain business for over 20 years, and we value professional judgement. We always put our client’s interest first. Our domain brokers pride themselves on a commitment to excellence. We are dedicated to upholding our founding principles E.T.H.I.C.S. Experience, Transparency, Honesty, Integrity, Confidentiality, and Service”. For more visit our Linkedin Page at: Domain Brokers at Prime Loyalty or Connect with us at: Linkedin | Twitter | Facebook | Pinterest | Instagram

Share article on social media or email:



Mount Sinai Launches Large-Scale Genetic Sequencing Project with the Regeneron Genetics Center


Getty Images

“For this project, we found several key ways to provide researchers with the massive, clinically focused, real-world data that are needed to truly determine the effectiveness of precision medicine and hopefully improve patient care,” – Alexander W. Charney, MD, PhD

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

The Program aims to enroll one million Mount Sinai patients over a five-year period, making it one of the most ambitious projects of its kind and the largest Regeneron-supported sequencing effort to date. Its goal is to provide researchers with a unique data set that will help them assess the true potential of genetics-based, precision medicine approaches to guide everyday patient care, as well as to generate new insights to guide the discovery and development of potential new therapies.

The collaboration team plans to combine the RGC’s massive gene sequencing capabilities and scientific research expertise with Mount Sinai’s large, diverse patient population and advanced electronic health records systems, all supported by a digital health platform developed by Vibrent Health.

“For decades, we have hoped that genetics would offer doctors the blueprints to each patient’s unique health care needs. While genetics has proved to be a powerful tool for understanding rare disorders, we still do not have enough data to know how effective it may be in helping to treat and diagnose most patients. A big reason for this is that most gene sequencing studies are not designed for this,” said Alexander W. Charney, MD, PhD, Associate Professor of Psychiatry, and Genetics and Genomic Sciences, at Icahn Mount Sinai and project leader.

“For this project, we found several key ways to provide researchers with the massive, clinically focused, real-world data that are needed to truly determine the effectiveness of precision medicine and hopefully improve patient care.”

One of those ways is to adopt streamlined approaches to the enrollment process, some of which were inspired by adjustments Dr. Charney and others had to make in 2020 during the peak of the COVID-19 pandemic.

“At the height of the pandemic, our interactions with patients were highly restricted. We knew that we wanted to study the genetics of these patients, and we already had blood samples. So out of necessity, we recruited the patients later by phone. To our surprise, this greatly increased recruitment rates,” said Dr. Charney. “Our ultimate hope is that we can use genetics to help all patients. Our experience with the pandemic strongly supports our expectation that this project can achieve what others haven’t: that is, to enroll a million patients in several years and deliver researchers the data needed to improve patient care, both in the short-term through customized care and in the longer term through the potential creation of brand-new diagnostic tests, treatments, and preventive measures.”

The project will also be led by Girish N. Nadkarni, MD, MPH, Irene and Dr. Arthur M. Fishberg Professor of Medicine; Dara Meyer, MS, PMP, Director of Operations and Project Management; and Rachelle Weisman, MPH, Associate Director of Clinical Operations, all at Icahn Mount Sinai.

Dr. Charney and Dr. Nadkarni were appointed recently as Co-Directors of The Charles Bronfman Institute for Personalized Medicine at Icahn Mount Sinai. The Mount Sinai Million Health Discoveries Program will be administered by the Institute, which spearheaded a forerunner of the program called BioMe, an electronic medical record-linked biobank.

The Program will be part of other initiatives within the Institute, including multimodal data science, deep phenotyping of patients with informative genetic variation, and last-mile experimental interventions to rigorously test new treatments before they are incorporated into clinical care.

Like many large genetic studies, the Mount Sinai Million Health Discoveries Program will enroll consenting patients; sequence and analyze their DNA; and then link their sequence data to anonymous, or “de-identified,” versions of their electronic medical records for researchers to study. Patients will be recruited at the Mount Sinai Health System, which handles about 4 million patients per year and stores their health data in its electronic medical records systems.

The RGC will perform exome sequencing and whole-genome genotyping by sequencing analysis on all DNA samples, as well as whole-genome sequencing on a large subset of samples. The RGC contributes similar work to the ongoing BioMe collaboration with Mount Sinai, which focuses on the broader relationship between health and the human genome. Vibrent Health, a leading digital health solutions company, will provide a robust privacy-preserving platform for e-consenting, data collection, and engagement for clinical research. The Program will also benefit from Vibrent’s experience as the technology platform for the National Institutes of Health’s million-person All of Us Research Program.

“The Regeneron Genetics Center uses the power of large-scale genomic sequencing to discover and develop better therapeutics for all,” said Aris Baras, MD, Senior Vice President at Regeneron and Head of the Regeneron Genetics Center. “By diversifying and expanding the population of participants in genomic studies, we can accelerate the time course for important new discoveries and the incorporation of genomics in medicine. The Mount Sinai patient population is spectacularly diverse and well-served by health care providers who truly believe in the potential of precision and genetics-based medicines as well as the application of genomics and digital health to improve health outcomes for all. We look forward to this impactful collaboration, as we strive to advance the future of medicine together.”

“At Mount Sinai, precision medicine rests on a three-legged stool of gene sequencing, advanced electronic medical records, and cutting-edge algorithmic data analysis techniques. This project exemplifies that highly promising approach,” said Eric J. Nestler, MD, PhD, Nash Family Professor of Neuroscience, Director of The Friedman Brain Institute, and Dean for Academic Affairs at Icahn Mount Sinai, and Chief Scientific Officer of the Mount Sinai Health System. “We expect that the unprecedented size and diversity of this study will provide researchers with clinically actionable information to deliver better care for patients.”

“Almost all the information we need for this study is already embedded in the electronic medical records. This means that we can greatly shorten the interview process, which in the past has reduced the chances a patient would consent to being enrolled in a study,” said Dr. Nadkarni. “In general, we believe that by re-evaluating each detailed step of the enrollment process, we can raise the participant levels we need to produce meaningful data that will one day help patients’ lives.”

Patient enrollment will begin in 2022. For more information:

https://icahn.mssm.edu/research/ipm/programs/mount-sinai-million

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter, and YouTube.

DecisionHealth is Celebrating its 25th Annual Private Duty National Conference and Expo October 17–19, 2022, at Caesars Palace in Las Vegas


“Private Duty agencies will have the opportunity to hear and exchange the latest insights with industry leaders about current issues, innovative trends, best practices and business strategies that can be implemented to improve your organization.”

DecisionHealth, an HCPro brand, is celebrating its 25th Annual Private Duty National Conference and Expo October 17–19, 2022, at Caesars Palace in Las Vegas. Attendees will hear company success stories on how to successfully generate referrals, stay ahead of the competition, accelerate growth, and capture market share, all while networking alongside hundreds of private duty executives from top-performing agencies.

Guy Tommasi Jr., managing director of LIFETIME Care at Home, LLC, says, “Private Duty agencies will have the opportunity to hear and exchange the latest insights with industry leaders about current issues, innovative trends, best practices, and business strategies that can be implemented to improve your organization.”

The main conference from October 18–19, 2022, features sessions that explore:


  • Operational strategies for improving and growing your homecare company;
  • Compliance strategies to stay ahead of changing wage and hour, legal, and HR rules;
  • A deep dive into how to partner with new payers and programs that are now willing to pay for private duty home care;
  • Marketing strategies to take your company to the next level;
  • Advice on how to diversify your services and grow your business;
  • Best practices on mastering client retention;
  • Strategies on how to position your agency as a key partner in value-based care; and
  • M&A valuations and exit strategies

In addition, there is a preconference on October 17 for attendees to receive additional education dedicated to recruitment and retention, featuring the latest best practices to hire, engage, and keep caregivers. Attendees are encouraged to take advantage of networking opportunities with like-minded executives to find their own niche and browse the exhibit hall filled with dozens of the latest solutions to help their agency increase revenue and referrals.

“For an owner to grow their agency … they must first grow themselves! That is why I love attending DecisionHealth’s Annual Private Duty National Conference & Expo,” expresses Clint Nobles, founder of HomeCareOps.com. “Each session provides insight into how owners and operators can take their teams and agencies to the next level; plus, meeting and mingling with all our fellow home care owners builds lasting relationships that will make the industry stronger in every way.”

Early-bird pricing is available through August 12, 2022. Register by visiting https://store.decisionhealth.com/private-duty.

Regarding COVID-19 safety and security measures:

We place the highest priority on the safety of our guests by following safety guidelines and advisement for meetings as outlined by state and local mandates. We will continue to monitor the COVID-19 environment and the recommended guidelines and communicate adjustments to the on-site policies and procedures as we approach the live event dates.

###

DecisionHealth, an HCPro brand, is the industry’s leading source for home health agencies and medical practice facilities to receive the latest news, analysis, and regulatory guidance on Medicare coding and reimbursement, benchmarks, payments, and Health Insurance Portability and Accountability Act (HIPAA) compliance through its flagship publications, as well as a wide selection of coding books, educational events, and online tools. Visit http://www.decisionhealth.com.

For over 34 years, HCPro, a division of Simplify Compliance LLC, has specialized in providing the latest healthcare regulatory information through industry-leading publications, continuing education, online coding platforms, instructor-led training, events, consulting services, and more to deliver consistent training, achieve compliance, and maximize workflow efficiencies, resulting in measurable performance and financial improvements. Visit http://www.hcpro.com/.

Share article on social media or email:

Society for Immunotherapy of Cancer Forward Fund Announces Recipients of Cancer Immunotherapy Fellowships and Technology Awards


Society for Immunotherapy of Cancer (SITC)

“Together with the immense generosity of our supporters, SITC is honored to help young investigators realize their cancer immunotherapy research dreams. It is our hope that these young researchers turn their dreams and ‘cure’ into a reality for all cancer patients.”

The Society for Immunotherapy of Cancer (SITC) Forward Fund is pleased to announce the recipients of the 2022 Fellowships and Technology Awards, which support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of novel research.

“Together with the immense generosity of our supporters, SITC is honored to help young investigators realize their cancer immunotherapy research dreams,” said SITC President Patrick Hwu, MD. “It is our hope that these young researchers turn their dreams and ‘cure’ into a reality for all cancer patients.”

These awards are financially supported through the Forward Fund, which was established by SITC in 2012 to stimulate the future of science, development and application of cancer immunology and immunotherapy through financially supporting its education and research. Since 2014, SITC has awarded more than $5 million in funding to deserving early career scientists in the field of cancer immunotherapy.

The 2022 SITC Fellowship and Technology Award recipients are:

SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship

Award Amount: $200,000 (two-year)

Awardee: Simone Minnie, PhD

Institution: Fred Hutchinson Cancer Research Center

Project Title: “Harnessing Treg fragility to improve anti-myeloma immune responses”

SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship

Award Amount: $100,000 (one-year)

Awardee: John Ligon, MD

Institution: University of Florida

Project Title: “Leveraging CD70 CXCR2-modified CAR T-cells for treating AML”

SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship

Award Amount: $100,000 (one-year)

Awardee: Jonathan Chen, MD, PhD

Institution: Massachusetts General Hospital

Project Title: “Dissecting the tumor immunity multicellular network”

SITC-Merck Cancer Immunotherapy Clinical Fellowship

Award Amount: $100,000 (one-year)

Awardee: Hitomi Hosoya, MD, PhD

Institution: Stanford University

Project Title: “Cell-free DNA-based Platform to Determine Treatment Response and Resistant Mechanisms to CAR T-cell Therapy in Multiple Myeloma”

SITC-Genentech Women in Cancer Immunotherapy Fellowship

Award Amount: $50,000 (one-year)

Awardee: Shu-chin Lai, PhD

Institution: Huntsman Cancer Institute, University of Utah

Project Title: “Augmenting T cell immunity to facilitate metastatic breast cancer treatment”

SITC-Nektar Therapeutics Equity and Inclusion in Cancer Immunotherapy Fellowship

Award Amount: $50,000 (one-year)

Awardee: Mara De Martino, PhD

Institution: Weill Cornell Medicine

Project Title: “Targeting FASN to sensitize irradiated glioblastoma to immunotherapy”

SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship

Award Amount: $40,000 (one-year)

Awardee: Steven Blum, MD

Institution: Dana-Farber Cancer Institute, Massachusetts General Hospital

Project Title: “Distinguishing Immune-Related Adverse Events (irAEs) from Anti-Tumor Immunity”

SITC-Natera ctDNA in Immunotherapy Response Monitoring Fellowship and Technology Award

Award: $40,000 and access to Natera’s Signatera™ testing technology

Awardee: Mariya Rozenblit, MD

Institution: Yale University

Project Title: “The tumor microenvironment of triple negative breast cancers with detectable circulating tumor DNA after pembrolizumab treatment”

SITC-NanoString Technologies Single Cell Biology Award

Award: Access to NanoString Technologies’ CosMx™ Spatial Molecular Imager (SMI)

Awardee: Elshad Hasanov, MD, PhD

Institution: University of Texas MD Anderson Cancer Center

Project Title: “CosMxing renal cell carcinoma brain metastases to decipher immune checkpoint inhibitor resistance mechanisms at single-cell and spatial context”

This year’s SITC Forward Fund Fellowships and Technology Awards were made possible through the generosity of Amgen, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Genentech, Mallinckrodt Pharmaceuticals, Merck, Nektar Therapeutics, NanoString Technologies and Natera Technologies. The fellowship and technology award recipients will be honored during a ceremony at the society’s 37th Annual Meeting at the Boston Convention and Exhibition Center in Boston, Massachusetts.

To learn more about current and past SITC Fellowship and Technology Award recipients, visit SITC’s website.

About SITC

Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.

Share article on social media or email:



Cone Health Extends its RelayOne Deployment for an Additional Five Years


RelayOne (http://www.RelayOne.com), a leading surgical care team collaboration and coordination solution provider, today announced that Cone Health, a not-for-profit health care network with four hospitals and three outpatient surgery centers that serves the citizens of Greensboro, N.C. and its surrounding counties, has extended its use of RelayOne’s platform for five more years. Cone Health first deployed RelayOne’s platform in 2020 so that its surgical care teams could see updates to their schedules, understand case readiness, and track case progress to make the best in-the-moment decisions about operational performance and staffing.

In May 2022, Cone Health surveyed its hospital administrators, surgical coordinators, nurses, surgeons, anesthesiologists, and others to learn more about their use of RelayOne. Among the survey response findings, Cone Health learned that its users saved an average of 37 minutes and more than 14 calls/texts/emails per day, per person. Across its entire user base, RelayOne saves Cone Health approximately 265 hours per day, which results in millions of dollars of labor efficiency gains each year. And with a high satisfaction rate, 95% of Cone Health users surveyed would recommend RelayOne to a colleague.

“The administrators, surgeons, anesthesiologists, nurses and others who are on, or support, our surgical care teams are always on the move, and so is the surgical schedule,” said Wayne McFatter, RN, MSN, CNOR, Co-Director of Perioperative Services for Cone Health. “So much of the operations of surgical services requires real-time information to make the best and most timely decisions. Staffing, case readiness, and changes to schedules all require that the right people get the right information and updates, right as they happen, right where they are. With RelayOne we can appropriately adjust and try to fine-tune our staffing by paying close attention to, and then acting on, the real-time notifications of OR facility changes, cancellations, case timing, and more.”

“RelayOne really helps us to keep up with what’s going on in our operating rooms, and helps us to improve OR utilization with their drill-down dashboards that give us a simple, snapshot look at all our trends,” said Sharon McCarter, RN, BSN, CNOR, MHA, Co-Director of Perioperative Services for Cone Health. “With RelayOne we can click one button on our phone and see our up-to-the-minute case count, after hours cases, productivity for the day, utilization for the day, and turnover times. And we can also look back at the days before and see how we did then, too. Ultimately, RelayOne helps us to minimize unnecessary surgery delays and cancellations, reduce staff frustrations, and smooth out our operations overall.”

“Coordinating the surgery schedule can often be a complex and dynamic process that hospital and operating room leaders face every day,” said Cam Sexton, CEO of RelayOne. “Many hospitals are still using outdated methods to coordinate schedules and changes with their surgical care team members. Our real-time, mobile platform makes it easy to proactively keep the entire surgical care team up-to-date on the latest updates, in and out, to and from, the operating room. We thank Cone Health for trusting us, and partnering with us for another five years, to help them to optimize their OR utilization, staffing and scheduling with our platform.”

Today, more hospitals and health systems are seeking new and innovative technology solutions to help surgical team members stay better connected and create a more efficient surgical operation.

The RelayOne platform delivers intuitive surgical collaboration, coordination and analytics that enable the surgical care team to easily and instantly access PHI-free surgical scheduling and case progress update information from anywhere, at any time.

RelayOne is easily integrated into the surgical care team workflow and EHR. Hospitals can go live on RelayOne in as little as four weeks and user onboarding and training takes just a few minutes.

About Cone Health

Cone Health is a national leader in quality, service and cost. The integrated health care network consists of Alamance Regional Medical Center, Annie Penn Hospital, Cone Health Behavioral Health Hospital, The Moses H. Cone Memorial Hospital, Wesley Long Hospital, Cone Health Medical Group, MedCenter High Point, MedCenter Kernersville, MedCenter Mebane, MedCenter for Women, Triad HealthCare Network, HealthTeam Advantage and various outpatient clinics and programs. More than 13,000 exceptional people provide exceptional care to the people of Guilford, Alamance, Rockingham, Forsyth, Caswell and Randolph counties.

About RelayOne

RelayOne provides software solutions accessible anytime, anywhere to healthcare providers for surgical care team collaboration. RelayOne reduces operational costs and increases margins with a quick-to-deploy and easy-to-use platform that is designed to optimize workflow through performance analytics, case readiness status updates, and real-time notification of surgical case changes, all without exposing protected health information (PHI). Some of the nation’s leading health systems rely on RelayOne to help them optimize the performance of their operating teams. To learn more about RelayOne visit http://www.RelayOne.com. RelayOne is a private equity-backed healthcare information technology provider headquartered in Durham, North Carolina.